70.73
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SF?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$70.82
Offen:
$71.48
24-Stunden-Volumen:
210.44K
Relative Volume:
0.15
Marktkapitalisierung:
$10.95B
Einnahmen:
$6.35B
Nettoeinkommen (Verlust:
$683.78M
KGV:
17.46
EPS:
4.0521
Netto-Cashflow:
$1.20B
1W Leistung:
-3.17%
1M Leistung:
-10.72%
6M Leistung:
-7.84%
1J Leistung:
+14.20%
Stifel Financial Corp Stock (SF) Company Profile
Firmenname
Stifel Financial Corp
Sektor
Branche
Telefon
314-342-2000
Adresse
ATTN: JAMES G. LASCHOBER, ST. LOUIS, MO
Compare SF vs MS, GS, SCHW, HOOD, IBKR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
SF
Stifel Financial Corp
|
70.75 | 10.96B | 6.35B | 683.78M | 1.20B | 4.0521 |
|
MS
Morgan Stanley
|
155.01 | 245.12B | 119.71B | 17.03B | 46.10B | 10.21 |
|
GS
Goldman Sachs Group Inc
|
787.15 | 233.70B | 126.15B | 17.18B | 23.15B | 51.30 |
|
SCHW
Charles Schwab Corp
|
93.44 | 159.87B | 27.68B | 8.85B | 13.27B | 4.6601 |
|
HOOD
Robinhood Markets Inc
|
73.48 | 68.53B | 4.51B | 1.88B | -3.42B | 2.059 |
|
IBKR
Interactive Brokers Group Inc
|
66.49 | 29.81B | 10.43B | 4.36B | 24.23B | 2.2152 |
Stifel Financial Corp Stock (SF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-12-11 | Fortgesetzt | UBS | Buy |
| 2025-10-08 | Hochstufung | TD Cowen | Hold → Buy |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-07-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-04-24 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2024-12-10 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-22 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-07-08 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-01-04 | Eingeleitet | TD Cowen | Outperform |
| 2022-11-22 | Eingeleitet | UBS | Neutral |
| 2022-10-12 | Eingeleitet | Citigroup | Neutral |
| 2021-06-23 | Hochstufung | Wolfe Research | Underperform → Outperform |
| 2021-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-01-05 | Herabstufung | Goldman | Buy → Neutral |
| 2021-01-05 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-06-23 | Eingeleitet | Credit Suisse | Neutral |
| 2020-05-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-01 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2019-05-30 | Eingeleitet | Compass Point | Buy |
| 2019-05-09 | Hochstufung | Goldman | Neutral → Buy |
| 2018-12-19 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-11-27 | Eingeleitet | Goldman | Neutral |
| 2018-10-03 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2018-01-08 | Hochstufung | Goldman | Neutral → Buy |
| 2018-01-03 | Hochstufung | Nomura | Neutral → Buy |
| 2017-12-01 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2017-05-23 | Herabstufung | Instinet | Buy → Neutral |
| 2017-03-20 | Herabstufung | Goldman | Buy → Neutral |
| 2016-11-28 | Herabstufung | Macquarie | Outperform → Neutral |
| 2016-02-22 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2016-01-12 | Hochstufung | Goldman | Sell → Buy |
| 2015-11-09 | Hochstufung | Nomura | Neutral → Buy |
| 2015-06-25 | Herabstufung | Goldman | Neutral → Sell |
| 2015-06-09 | Bestätigt | Credit Suisse | Neutral |
| 2015-03-19 | Eingeleitet | MKM Partners | Buy |
Alle ansehen
Stifel Financial Corp Aktie (SF) Neueste Nachrichten
Stifel reiterates Buy rating on Mineralys stock, $52 target - Investing.com
Stifel reiterates Buy rating on Erasca stock, $20 target - Investing.com
Stifel cuts Health Catalyst stock price target on migration woes - Investing.com
WELL Health could soon free up a ton of cash, Stifel says - Cantech Letter
Stifel Financial Corp. Announces Appointment of Managing Directors - marketscreener.com
Stifel reiterates Codexis stock Buy rating on solid 2026 guidance - Investing.com
Stifel reiterates Buy on Pattern Group stock citing growth rates - Investing.com
Stifel Welcomes Veteran Healthcare Bankers Ajay Pathak and Bill Reisner as Managing Directors in Public Finance - The Globe and Mail
Two veteran healthcare bankers join Stifel to help hospitals raise capital - Stock Titan
Stifel reiterates Foghorn Therapeutics stock rating at buy - Investing.com
Stifel maintains Hold on Papa John’s stock amid buyout offer - Investing.com
Stifel reiterates Cintas stock Hold rating after UniFirst deal - Investing.com
Stifel Nicolaus Lowers Martin Midstream Partners (NASDAQ:MMLP) Price Target to $3.00 - MarketBeat
Campbell's (NASDAQ:CPB) Given New $25.00 Price Target at Stifel Nicolaus - MarketBeat
Minerva Neurosciences to Participate in The Stifel 2026 Virtual CNS Forum - Yahoo Finance
Stifel reiterates Regenxbio stock rating on Duchenne trial data - Investing.com
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026 - Yahoo Finance
Stifel cuts Campbell Soup stock price target on weaker outlook - Investing.com
Stifel reiterates Buy on TXO Energy stock after asset sale - Investing.com
Stifel reiterates Buy rating on Kamada stock, $11 price target - Investing.com
Stifel reiterates Buy rating on Equinix stock after CFO appointment - Investing.com
Stifel reiterates Credo Technology stock rating on AEC market lead - Investing.com
Stifel cuts Oracle stock price target on valuation, keeps buy rating - Investing.com
Stifel reiterates Target Hospitality stock rating on new contracts By Investing.com - Investing.com South Africa
Stifel cuts Carnival stock price target on fuel costs, geopolitics - Investing.com
Stifel reiterates Target Hospitality stock rating on new contracts - Investing.com Australia
Stifel cuts AeroVironment stock price target on contract loss - Investing.com
Stifel reiterates Custom Truck One Source stock Buy rating at $8 By Investing.com - Investing.com South Africa
2 Reasons SF is Risky and 1 Stock to Buy Instead - Finviz
Neurocrine Biosciences to Present at the Stifel 2026 Virtual CNS Forum - Yahoo Finance
Alkermes to Present at the Stifel 2026 Virtual CNS Forum - Yahoo Finance
Stifel reiterates DraftKings stock Buy rating on super app strategy - Investing.com
Stifel reiterates Buy on Brightstar Lottery stock, cites resilience - Investing.com
Doman Building Materials Group (TSE:DBM) Given New C$11.50 Price Target at Stifel Nicolaus - MarketBeat
Stifel reaffirms Revolve Group stock rating on brand launch - Investing.com
Stifel reiterates Buy on Olema stock after Roche trial miss - Investing.com
Stifel raises TransMedics stock price target to $130 on liver strength - Investing.com
Stifel reiterates Incyte stock rating after FDA setback - Investing.com
Stifel raises Tango Therapeutics stock price target on PRMT5 data - Investing.com
Stifel initiates Anadarko Petroleum stock with buy on growth outlook - Investing.com
Assessing Stifel Financial (SF) Valuation After Recent Share Price Weakness - Sahm
Stifel Financial Corp (SF) Trading Down 3.34% on Mar 6 - GuruFocus
Stifel Lowers Its Price Target on Eos Energy Enterprises, Inc. (EOSE) to Maintains a Buy Rating - Yahoo Finance
CLAR: Stifel Maintains Buy Rating, Lowers Price Target | CLAR St - GuruFocus
CIEN: Stifel Raises Price Target and Reiterates Buy Rating | CIE - GuruFocus
Clarus (NASDAQ:CLAR) Price Target Cut to $6.00 by Analysts at Stifel Nicolaus - MarketBeat
The Bull Case For Stifel Financial (SF) Could Change Following New ERISA Class Action Over 401(k) Funds - simplywall.st
Stifel raises Plains GP Holdings stock price target on capex outlook - Investing.com
Stifel reiterates Buy on BridgeBio Oncology stock, $23 target - Investing.com
Stifel raises Plains All American stock price target on capex cut - Investing.com
Stifel cuts Pattern Group stock price target to $21 on estimates - Investing.com
Finanzdaten der Stifel Financial Corp-Aktie (SF)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):